Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18

1.

The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia.

Cropley VL, Scarr E, Fornito A, Klauser P, Bousman CA, Scott R, Cairns MJ, Tooney PA, Pantelis C, Dean B.

Psychiatry Res. 2015 Nov 30;234(2):182-7. doi: 10.1016/j.pscychresns.2015.09.004. Epub 2015 Sep 10.

PMID:
26481978
2.

Microglial activation and progressive brain changes in schizophrenia.

Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C.

Br J Pharmacol. 2016 Feb;173(4):666-80. doi: 10.1111/bph.13364. Epub 2016 Jan 8. Review.

PMID:
26455353
3.

Investigation of orbitofrontal sulcogyral pattern in chronic schizophrenia.

Cropley VL, Bartholomeusz CF, Wu P, Wood SJ, Proffitt T, Brewer WJ, Desmond PM, Velakoulis D, Pantelis C.

Psychiatry Res. 2015 Nov 30;234(2):280-3. doi: 10.1016/j.pscychresns.2015.09.001. Epub 2015 Sep 5.

PMID:
26409572
4.

Delayed Development of Brain Connectivity in Adolescents With Schizophrenia and Their Unaffected Siblings.

Zalesky A, Pantelis C, Cropley V, Fornito A, Cocchi L, McAdams H, Clasen L, Greenstein D, Rapoport JL, Gogtay N.

JAMA Psychiatry. 2015 Sep;72(9):900-8. doi: 10.1001/jamapsychiatry.2015.0226.

PMID:
26176706
5.

Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.

Cropley VL, Lin A, Nelson B, Reniers RL, Yung AR, Bartholomeusz CF, Klauser P, Velakoulis D, McGorry P, Wood SJ, Pantelis C.

Schizophr Res. 2015 May 29. pii: S0920-9964(15)00271-6. doi: 10.1016/j.schres.2015.05.014. [Epub ahead of print]

PMID:
26032566
6.

Using longitudinal imaging to map the 'relapse signature' of schizophrenia and other psychoses.

Cropley VL, Pantelis C.

Epidemiol Psychiatr Sci. 2014 Sep;23(3):219-25. doi: 10.1017/S2045796014000341. Epub 2014 May 22.

PMID:
24849668
7.

Examining the cognitive effects of a special extract of Bacopa monniera (CDRI08: Keenmnd): a review of ten years of research at Swinburne University.

Stough C, Scholey A, Cropley V, Wesnes K, Zangara A, Pase M, Savage K, Nolidin K, Lomas J, Downey L.

J Pharm Pharm Sci. 2013;16(2):254-8. Review.

8.
10.

Does coffee enriched with chlorogenic acids improve mood and cognition after acute administration in healthy elderly? A pilot study.

Cropley V, Croft R, Silber B, Neale C, Scholey A, Stough C, Schmitt J.

Psychopharmacology (Berl). 2012 Feb;219(3):737-49. doi: 10.1007/s00213-011-2395-0. Epub 2011 Jul 20.

PMID:
21773723
11.

Effects of 2G and 3G mobile phones on performance and electrophysiology in adolescents, young adults and older adults.

Leung S, Croft RJ, McKenzie RJ, Iskra S, Silber B, Cooper NR, O'Neill B, Cropley V, Diaz-Trujillo A, Hamblin D, Simpson D.

Clin Neurophysiol. 2011 Nov;122(11):2203-16. doi: 10.1016/j.clinph.2011.04.006. Epub 2011 May 12.

PMID:
21570341
12.

Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.

Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB.

Psychiatry Res. 2008 Jul 15;163(2):171-82. doi: 10.1016/j.pscychresns.2007.11.003. Epub 2008 May 27.

PMID:
18504119
13.

Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.

Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M.

Synapse. 2008 Jun;62(6):399-408. doi: 10.1002/syn.20506.

PMID:
18361438
14.

Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.

Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW.

J Med Chem. 2008 Jan 10;51(1):17-30. Epub 2007 Dec 8.

PMID:
18067245
15.

Molecular imaging of the dopaminergic system and its association with human cognitive function.

Cropley VL, Fujita M, Innis RB, Nathan PJ.

Biol Psychiatry. 2006 May 15;59(10):898-907. Review.

PMID:
16682268
16.

Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans.

Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, Nathan PJ, Pike VW, Innis RB.

J Nucl Med. 2006 Jan;47(1):100-4.

17.

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.

Fujita M, Ichise M, Zoghbi SS, Liow JS, Ghose S, Vines DC, Sangare J, Lu JQ, Cropley VL, Iida H, Kim KM, Cohen RM, Bara-Jimenez W, Ravina B, Innis RB.

Ann Neurol. 2006 Jan;59(1):174-7.

18.

Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET.

Fujita M, Zoghbi SS, Crescenzo MS, Hong J, Musachio JL, Lu JQ, Liow JS, Seneca N, Tipre DN, Cropley VL, Imaizumi M, Gee AD, Seidel J, Green MV, Pike VW, Innis RB.

Neuroimage. 2005 Jul 15;26(4):1201-10.

PMID:
15961054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk